Non-small cell lung cancer

Common Name(s)

Non-small cell lung cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Non-small cell lung cancer" for support, advocacy or research.

Free to Breathe

Free to Breathe is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals and industry leaders united in the belief that every person with lung cancer deserves a cure. Free to Breathe is dedicated to doubling lung cancer survival by 2022.

Last Updated: 16 Oct 2014

View Details
Logo
Lung Cancer Foundation of America

LCFA’s mission is the dramatic improvement in survivorship of lung cancer patients through the funding of transformative science, with the ultimate goal of curing the disease. To accomplish this, LCFA will work to raise both the funds and the national profile of lung cancer in order to substantially increase support of innovative and groundbreaking research efforts.

Last Updated: 28 Aug 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Non-small cell lung cancer" for support, advocacy or research.

Free to Breathe

Free to Breathe is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals and industry leaders united in the belief that every person with lung cancer deserves a cure. Free to Breathe is dedicated to doubling lung cancer survival by 2022.

http://www.freetobreathe.org

Last Updated: 16 Oct 2014

View Details
Logo
Lung Cancer Foundation of America

LCFA’s mission is the dramatic improvement in survivorship of lung cancer patients through the funding of transformative science, with the ultimate goal of curing the disease. To accomplish this, LCFA will work to raise both the funds and the national profile of lung cancer in order to substantially increase support of innovative and groundbreaking research efforts.

http://www.LCFAmerica.org

Last Updated: 28 Aug 2014

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Non-small cell lung cancer" returned 4138 free, full-text research articles on human participants. First 3 results:

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
 

Author(s): Alice T Shaw, Benjamin J Solomon

Journal: N. Engl. J. Med.. 2015 Feb;372(7):683-4.

 

Last Updated: 12 Feb 2015

Go To URL
Effect of ginseng polysaccharides and dendritic cells on the balance of Th1/Th2 T helper cells in patients with non-small cell lung cancer.
 

Author(s): Junjie Ma, Huiping Liu, Xiaolong Wang

Journal: J Tradit Chin Med. 2014 Dec;34(6):641-5.

 

To investigate the effect of thorascopic administration.of ginseng polysaccharides (GPS) plus dendritic cells (DC) on T helper cell type 1/T helper cell type 2 (Th1/Th2) balance in patients with non-small cell lung cancer (NSCLC).

Last Updated: 26 Jan 2015

Go To URL
Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
 

Author(s): Tae-kyung Kwak, Eun Jung Sohn, Sunhee Kim, Gunho Won, Jeong-Un Choi, Kwon Jeong, Myoungseok Jeong, Oh Sung Kwon, Sung-Hoon Kim

Journal:

 

Osteopontin (OPN) is one of important molecular targets in cancer progression, metastasis as a calcium-binding, extracellular-matrix-associated protein of the small integrin-binding ligand and, N-linked glycoprotein. In the present study, anti-metastatic mechanism of ethanol extracts ...

Last Updated: 1 Nov 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Non-small cell lung cancer" returned 485 free, full-text review articles on human participants. First 3 results:

ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.
 

Author(s): Joe Yujiao Chang, Larry L Kestin, R Bryan Barriger, Indrin J Chetty, Mark E Ginsburg, Sanath Kumar, Billy W Loo, Benjamin Movsas, Andreas Rimner, Kenneth E Rosenzweig, Thomas E Stinchcombe, Gregory M M Videtic, Henning Willers

Journal:

 

Concurrent chemotherapy/radiotherapy has been considered the standard treatment for patients with a good performance status and inoperable stage III non-small-cell lung cancer (NSCLC). Three-dimensional chemoradiation therapy and intensity-modulated radiation therapy have been reported ...

Last Updated: 21 Aug 2014

Go To URL
First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era.
 

Author(s): Enrica Capelletto, Silvia Novello, Giorgio V Scagliotti

Journal: Future Oncol. 2014 May;10(6):1081-93.

 

Lung cancer is the leading cause of cancer-related mortality worldwide in both sexes, expected to account, in the near future, for more than 30% of all cancer-related deaths. Recently, improvements in the systemic therapy of non-small-cell lung cancer according to histology and tumor ...

Last Updated: 19 Jun 2014

Go To URL
Effectiveness and safety of pemetrexed versus docetaxel as a treatment for advanced non-small cell lung cancer: a systematic review and meta-analysis.
 

Author(s): Bao-Shan Di, Kong-Ping Wei, Jin-Hui Tian, Xiao-Juan Xiao, Yan Li, Xu-Hui Zhang, Qin Yu, Ke-Hu Yang, Long Ge, Wen-Hui Huang, Fang-Wa Zhang

Journal: Asian Pac. J. Cancer Prev.. 2014 ;15(8):3419-24.

 

Our aim was to conduct a meta-analysis to compare the efficacy and safety of pemetrexed and docetaxel for non-small cell lung cancer (NSCLC).

Last Updated: 29 May 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
 

Status: Recruiting

Condition Summary: Non-small Cell Lung Cancer; Advanced Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer

 

Last Updated: 9 Dec 2014

Go to URL
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
 

Status: Recruiting

Condition Summary: Cachexia; Fatigue; Pulmonary Complications; Radiation Toxicity; Recurrent Non-small Cell Lung Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer

 

Last Updated: 17 Mar 2015

Go to URL
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
 

Status: Recruiting

Condition Summary: Non-small Cell Lung Cancer; Progression of Non-small Cell Lung Cancer; Non-small Cell Lung Cancer Recurrent

 

Last Updated: 9 Feb 2015

Go to URL